COMPARISON OF RENIN AND CONVERTING ENZYME-INHIBITION IN SODIUM-DEFICIENT DOGS

被引：28

作者：

BLAINE, EH ^{[1
]}

NELSON, BJ ^{[1
]}

SEYMOUR, AA ^{[1
]}

SCHORN, TW ^{[1
]}

SWEET, CS ^{[1
]}

SLATER, EE ^{[1
]}

NUSSBERGER, J ^{[1
]}

BOGER, J ^{[1
]}

机构：

[1] MERCK INST THERAPEUT RES, MERCK SHARP & DOHME RES LABS, RAHWAY, NJ 07065 USA

来源：

HYPERTENSION | 1985年 / 7卷 / 03期

关键词：

D O I：

10.1161/01.HYP.7.3_Pt_2.I66

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：I66 / I71

页数：6

共 35 条

[1] PRESSOR-RESPONSE TO 1-SAR-8-ALA-ANGIOTENSINII (SARALASIN) IN HYPERTENSIVE SUBJECTS
ANDERSON, GH
STREETEN, DHP
DALAKOS, TG
[J]. CIRCULATION RESEARCH, 1977, 40 (03) : 243 - 250
[2] VASCULAR WALL RENIN IN SPONTANEOUSLY HYPERTENSIVE RATS - POTENTIAL RELEVANCE TO HYPERTENSION MAINTENANCE AND ANTIHYPERTENSIVE EFFECT OF CAPTOPRIL
ASAAD, MM
ANTONACCIO, MJ
[J]. HYPERTENSION, 1982, 4 (04) : 487 - 493
[3] STATINE-CONTAINING RENIN INHIBITOR - DISSOCIATION OF BLOOD-PRESSURE LOWERING AND RENIN INHIBITION IN SODIUM-DEFICIENT DOGS
BLAINE, EH
SCHORN, TW
BOGER, J
[J]. HYPERTENSION, 1984, 6 (02) : I111 - I118
[4] BLAIRWEST JR, 1971, AM J PHYSIOL, V220, P1309
[5] NOVEL RENIN INHIBITORS CONTAINING THE AMINO-ACID STATINE
BOGER, J
LOHR, NS
ULM, EH
POE, M
BLAINE, EH
FANELLI, GM
LIN, TY
PAYNE, LS
SCHORN, TW
LAMONT, BI
VASSIL, TC
STABILITO, II
VEBER, DF
RICH, DH
BOPARI, AS
[J]. NATURE, 1983, 303 (5912) : 81 - 84
[6] ROLE OF KININS IN THE ACUTE ANTIHYPERTENSIVE EFFECT OF THE CONVERTING ENZYME-INHIBITOR, CAPTOPRIL
CARRETERO, OA
MIYAZAKI, S
SCICLI, AG
[J]. HYPERTENSION, 1981, 3 (01) : 18 - 22
[7] ROLE OF ANGIOTENSIN IN THE CONTROL OF BLOOD-PRESSURE DURING SODIUM DEPLETION
CONWAY, J
HATTON, R
KEDDIE, J
DAWES, P
[J]. HYPERTENSION, 1979, 1 (04) : 402 - 409
[8] ANGIOTENSIN-I CONVERTING ENZYME
ERDOS, EG
[J]. CIRCULATION RESEARCH, 1975, 36 (02) : 247 - 255
[9] COMPARATIVE-STUDY OF AN ANGIOTENSIN-II ANALOG AND A CONVERTING ENZYME-INHIBITOR
FAGARD, RH
AMERY, AK
LIJNEN, PJ
REYBROUCK, TM
[J]. KIDNEY INTERNATIONAL, 1980, 17 (05) : 647 - 653
[10] HEMODYNAMIC AND ANTIHYPERTENSIVE EFFECTS OF THE NEW ORAL ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR MK-421 (ENALAPRIL)
FOUAD, FM
TARAZI, RC
BRAVO, EL
TEXTOR, SC
[J]. HYPERTENSION, 1984, 6 (02) : 167 - 174

← 1 2 3 4 →